Thalidomide-induced organizing pneumonia

Ashley A. Feaver; David E. McCune; Angela G. Mysliwiec; Vincent Mysliwiec

doi:10.1097/01.smj.0000233182.06540.00

Thalidomide-induced organizing pneumonia

Ashley A. Feaver
, David E. McCune
, Angela G. Mysliwiec
, Vincent Mysliwiec

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

Twenty medications are associated with drug-induced organizing pneumonia; however, thalidomide is not listed as a potential causative agent. Thalidomide (Thalomid, Celgene Corp., Summit, NJ), an angiogenesis inhibitor and immunomodulator that reduces tumor necrosis factor-alpha, is used for the treatment of multiple myeloma. We report a case of organizing pneumonia in a 58-year-old male with multiple myeloma treated with dexamethasone and thalidomide.

Original language	English (US)
Pages (from-to)	1292-1294
Number of pages	3
Journal	Southern medical journal
Volume	99
Issue number	11
DOIs	https://doi.org/10.1097/01.smj.0000233182.06540.00
State	Published - Nov 2006
Externally published	Yes

Keywords

Multiple myeloma
Organizing pneumonia
Pulmonary toxicity
Thalidomide

ASJC Scopus subject areas

General Medicine

Access to Document

10.1097/01.smj.0000233182.06540.00

Cite this

@article{6c9c7ea470ff4bc8886b650e69e93e9c,

title = "Thalidomide-induced organizing pneumonia",

abstract = "Twenty medications are associated with drug-induced organizing pneumonia; however, thalidomide is not listed as a potential causative agent. Thalidomide (Thalomid, Celgene Corp., Summit, NJ), an angiogenesis inhibitor and immunomodulator that reduces tumor necrosis factor-alpha, is used for the treatment of multiple myeloma. We report a case of organizing pneumonia in a 58-year-old male with multiple myeloma treated with dexamethasone and thalidomide.",

keywords = "Multiple myeloma, Organizing pneumonia, Pulmonary toxicity, Thalidomide",

author = "Feaver, \{Ashley A.\} and McCune, \{David E.\} and Mysliwiec, \{Angela G.\} and Vincent Mysliwiec",

year = "2006",

month = nov,

doi = "10.1097/01.smj.0000233182.06540.00",

language = "English (US)",

volume = "99",

pages = "1292--1294",

journal = "Southern medical journal",

issn = "0038-4348",

publisher = "Lippincott Williams and Wilkins",

number = "11",

}

TY - JOUR

T1 - Thalidomide-induced organizing pneumonia

AU - Feaver, Ashley A.

AU - McCune, David E.

AU - Mysliwiec, Angela G.

AU - Mysliwiec, Vincent

PY - 2006/11

Y1 - 2006/11

N2 - Twenty medications are associated with drug-induced organizing pneumonia; however, thalidomide is not listed as a potential causative agent. Thalidomide (Thalomid, Celgene Corp., Summit, NJ), an angiogenesis inhibitor and immunomodulator that reduces tumor necrosis factor-alpha, is used for the treatment of multiple myeloma. We report a case of organizing pneumonia in a 58-year-old male with multiple myeloma treated with dexamethasone and thalidomide.

AB - Twenty medications are associated with drug-induced organizing pneumonia; however, thalidomide is not listed as a potential causative agent. Thalidomide (Thalomid, Celgene Corp., Summit, NJ), an angiogenesis inhibitor and immunomodulator that reduces tumor necrosis factor-alpha, is used for the treatment of multiple myeloma. We report a case of organizing pneumonia in a 58-year-old male with multiple myeloma treated with dexamethasone and thalidomide.

KW - Multiple myeloma

KW - Organizing pneumonia

KW - Pulmonary toxicity

KW - Thalidomide

UR - https://www.scopus.com/pages/publications/33845335449

UR - https://www.scopus.com/pages/publications/33845335449#tab=citedBy

U2 - 10.1097/01.smj.0000233182.06540.00

DO - 10.1097/01.smj.0000233182.06540.00

M3 - Article

C2 - 17195429

AN - SCOPUS:33845335449

SN - 0038-4348

VL - 99

SP - 1292

EP - 1294

JO - Southern medical journal

JF - Southern medical journal

IS - 11

ER -

Thalidomide-induced organizing pneumonia

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this